Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis

被引:12
作者
Fujita, Yusuke [1 ]
Matsuda, Sachiko [2 ]
Sasaki, Yasushi [3 ]
Masugi, Yohei [4 ]
Kitago, Minoru [1 ]
Yagi, Hiroshi [1 ]
Abe, Yuta [1 ]
Shinoda, Masahiro [1 ]
Tokino, Takashi [3 ]
Sakamoto, Michiie [4 ]
Kitagawa, Yuko [1 ]
机构
[1] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan
[2] Keio Univ, Endowed Res Chair Mol Targeted Therapy Gastrointe, Sch Med, Tokyo, Japan
[3] Sapporo Med Univ, Res Inst Frontier Med, Dept Med Genome Sci, Sapporo, Hokkaido, Japan
[4] Keio Univ, Dept Pathol, Sch Med, Tokyo, Japan
基金
日本学术振兴会;
关键词
multicentric occurrence; multiple pancreatic cancers; next-generation sequence; pancreatic carcinogenesis; pancreatic intraepithelial neoplasia; NEOPLASTIC PRECURSOR LESIONS; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINOMA; CLASSIFICATION-SYSTEM; SUBTYPES; MARKER; INSTABILITY; KRAS;
D O I
10.1111/cas.14268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are increased opportunities in oncology clinics to identify multiple pancreatic ductal adenocarcinomas (PDAC) that co-occur simultaneously or arise metachronously in the pancreatic parenchyma, yet their pathogenesis remains elusive. We hypothesized that two potential pathways, multicentric carcinogenesis and intrapancreatic metastasis, might contribute to forming multiple PDAC. Among 241 resected cases, we identified 20 cancer nodules from nine patients with multiple PDAC (six with synchronous PDAC, one with metachronous PDAC, and two with both synchronous and metachronous PDAC). Integrated clinical, pathological, and mutational analyses, using TP53 and SMAD4 immunostaining and targeted next-generation sequencing of 50 cancer-related genes, were conducted to examine the intertumor relationships. Four of the nine patients were assessed as having undergone multicentric carcinogenesis because of heterogeneity of immunohistochemical and/or mutation characteristics. In contrast, tumors in the other five patients showed intertumor molecular relatedness. Two of these five patients, available for matched sequencing data, showed two or more shared mutations. Moreover, all the smaller nodules in these five patients showed identical TP53 and SMAD4 expression patterns to the corresponding main tumors. Consequently, these five patients were considered to have undergone intrapancreatic metastasis. None of the five smaller nodules arising from intrapancreatic metastasis was accompanied by pancreatic intraepithelial neoplasia, and three of them were tiny (<= 1mm). Patients whose tumors resulted from intrapancreatic metastasis appeared to have higher disease stages and worse outcome than those with tumors from multicentric carcinogenesis. Our results provide insight into pancreatic carcinogenesis, showing that the development of multiple PDAC involves distinct evolutionary paths that potentially affect patient prognosis.
引用
收藏
页码:739 / 748
页数:10
相关论文
共 52 条
  • [1] Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
    Aguirre, Andrew J.
    Nowak, Jonathan A.
    Camarda, Nicholas D.
    Moffitt, Richard A.
    Ghazani, Arezou A.
    Hazar-Rethinam, Mehlika
    Raghavan, Srivatsan
    Kim, Jaegil
    Brais, Lauren K.
    Ragon, Dorisanne
    Welch, Marisa W.
    Reilly, Emma
    McCabe, Devin
    Marini, Lori
    Anderka, Kristin
    Helvie, Karla
    Oliver, Nelly
    Babic, Ana
    Da Silva, Annacarolina
    Nadres, Brandon
    Van Seventer, Emily E.
    Shahzade, Heather A.
    St Pierre, Joseph P.
    Burke, Kelly P.
    Clancy, Thomas
    Cleary, James M.
    Doyle, Leona A.
    Jajoo, Kunal
    McCleary, Nadine J.
    Meyerhardt, Jeffrey A.
    Murphy, Janet E.
    Ng, Kimmie
    Patel, Anuj K.
    Perez, Kimberly
    Rosenthal, Michael H.
    Rubinson, Douglas A.
    Ryou, Marvin
    Shapiro, Geoffrey I.
    Sicinska, Ewa
    Silverman, Stuart G.
    Nagy, Rebecca J.
    Lanman, Richard B.
    Knoerzer, Deborah
    Welsch, Dean J.
    Yurgelun, Matthew B.
    Fuchs, Charles S.
    Garraway, Levi A.
    Getz, Gad
    Hornick, Jason L.
    Johnson, Bruce E.
    [J]. CANCER DISCOVERY, 2018, 8 (09) : 1096 - 1111
  • [2] [Anonymous], 2010, WHO Classification of tumors of the digestive system
  • [3] Genomic analyses identify molecular subtypes of pancreatic cancer
    Bailey, Peter
    Chang, David K.
    Nones, Katia
    Johns, Amber L.
    Patch, Ann-Marie
    Gingras, Marie-Claude
    Miller, David K.
    Christ, Angelika N.
    Bruxner, Tim J. C.
    Quinn, Michael C.
    Nourse, Craig
    Murtaugh, L. Charles
    Harliwong, Ivon
    Idrisoglu, Senel
    Manning, Suzanne
    Nourbakhsh, Ehsan
    Wani, Shivangi
    Fink, Lynn
    Holmes, Oliver
    Chin, Vencssa
    Anderson, Matthew J.
    Kazakoff, Stephen
    Leonard, Conrad
    Newell, Felicity
    Waddell, Nick
    Wood, Scott
    Xu, Qinying
    Wilson, Peter J.
    Cloonan, Nicole
    Kassahn, Karin S.
    Taylor, Darrin
    Quek, Kelly
    Robertson, Alan
    Pantano, Lorena
    Mincarelli, Laura
    Sanchez, Luis N.
    Evers, Lisa
    Wu, Jianmin
    Pinese, Mark
    Cowley, Mark J.
    Jones, Marc D.
    Colvin, Emily K.
    Nagrial, Adnan M.
    Humphrey, Emily S.
    Chantrill, Lorraine A.
    Mawson, Amanda
    Humphris, Jeremy
    Chou, Angela
    Pajic, Marina
    Scarlett, Christopher J.
    [J]. NATURE, 2016, 531 (7592) : 47 - +
  • [4] A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
    Basturk, Olca
    Hong, Seung-Mo
    Wood, Laura D.
    Adsay, N. Volkan
    Albores-Saavedra, Jorge
    Biankin, Andrew V.
    Brosens, Lodewijk A. A.
    Fukushima, Noriyoshi
    Goggins, Michael
    Hruban, Ralph H.
    Kato, Yo
    Klimstra, David S.
    Kloeppel, Guenter
    Krasinskas, Alyssa
    Longnecker, Daniel S.
    Matthaei, Hanno
    Offerhaus, G. Johan A.
    Shimizu, Michio
    Takaori, Kyoichi
    Terris, Benoit
    Yachida, Shinichi
    Esposito, Irene
    Furukawa, Toru
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (12) : 1730 - 1741
  • [5] Brune K, 2006, AM J SURG PATHOL, V30, P1067
  • [6] The patterns and dynamics of genomic instability in metastatic pancreatic cancer
    Campbell, Peter J.
    Yachida, Shinichi
    Mudie, Laura J.
    Stephens, Philip J.
    Pleasance, Erin D.
    Stebbings, Lucy A.
    Morsberger, Laura A.
    Latimer, Calli
    McLaren, Stuart
    Lin, Meng-Lay
    McBride, David J.
    Varela, Ignacio
    Nik-Zainal, Serena A.
    Leroy, Catherine
    Jia, Mingming
    Menzies, Andrew
    Butler, Adam P.
    Teague, Jon W.
    Griffin, Constance A.
    Burton, John
    Swerdlow, Harold
    Quail, Michael A.
    Stratton, Michael R.
    Iacobuzio-Donahue, Christine
    Futreal, P. Andrew
    [J]. NATURE, 2010, 467 (7319) : 1109 - 1113
  • [7] Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
    Canto, Marcia Irene
    Almario, Jose Alejandro
    Schulick, Richard D.
    Yeo, Charles J.
    Klein, Alison
    Blackford, Amanda
    Shin, Eun Ji
    Sanyal, Abanti
    Yenokyan, Gayane
    Lennon, Anne Marie
    Kamel, Ihab R.
    Fishman, Elliot K.
    Wolfgang, Christopher
    Weiss, Matthew
    Hruban, Ralph H.
    Goggins, Michael
    [J]. GASTROENTEROLOGY, 2018, 155 (03) : 740 - +
  • [8] Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma
    Chuma, M
    Sakamoto, M
    Yamazaki, K
    Ohta, T
    Ohki, M
    Asaka, M
    Hirohashi, S
    [J]. HEPATOLOGY, 2003, 37 (01) : 198 - 207
  • [9] 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
    Chun, Yun Shin
    Pawlik, Timothy M.
    Vauthey, Jean-Nicolas
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 845 - 847
  • [10] KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
    Cicenas, Jonas
    Kvederaviciute, Kotryna
    Meskinyte, Ingrida
    Meskinyte-Kausiliene, Edita
    Skeberdyte, Aiste
    Cicenas, Jonas, Jr.
    [J]. CANCERS, 2017, 9 (05):